文献速递白血病淋巴瘤

儿童急性淋巴细胞白血病的显性与隐性遗传病因

Overt and covert genetic causes of pediatric acute lymphoblastic leukemia.
PubMed 文献 · Leukemia · 2025-03-24

儿童急性淋巴细胞白血病(pALL)是最常见的儿童恶性肿瘤,但病因尚未完全明确。本文综述了三轮胚系遗传研究发现的13种癌症易感综合征(CPS),其中7种为显性CPS、6种为隐性CPS,合计影响约1/450新生儿,仅少数会发病。文章探讨这些CPS是否需要专门的诊断、治疗和长期管理策略,并强调国际合作研究的重要性。

要点

  • 13种癌症易感综合征是pALL已知的主要遗传病因,合计影响约1/450新生儿。
  • 6种新描述的CPS呈隐性,仅表现轻微或无癌症外特征。
  • 21三体已有专门的白血病诊疗方案,其他12种CPS的专科照护需求多未被充分明确或满足。

核心结论

  • 13种癌症易感综合征是pALL的主要已知遗传病因,合计影响约1/450新生儿,其中仅少数会发病。
  • 21三体的专科白血病照护方案已获认可,其他12种与pALL高风险相关的CPS也可能从专科照护中获益,但这些需求在临床上常未被充分明确或满足。
  • 鉴于每种综合征均罕见,国际合作研究与共享数据对推进知识和改善患者结局至关重要。

研究设计与样本

  • 本文为综述,总结三轮胚系遗传研究中发现的与pALL相关的癌症易感综合征。

主要发现

  • 7种显性癌症易感综合征具有广泛临床表型,包括pALL风险升高。
  • 6种新描述的癌症易感综合征呈隐性,仅表现轻微或无癌症外特征。
  • 人类泛基因组数据表明,与这些疾病相关基因的突变受到强烈的负选择。
  • 13种癌症易感综合征合计影响约1/450新生儿,其中仅少数会发展为该病。

关键数值与推荐

  • 13种癌症易感综合征中,7种为显性CPS,6种为隐性CPS。
  • 13种CPS合计影响约1/450新生儿。

临床怎么用

  • 21三体患儿已有专门的白血病照护方案。
  • 作者探讨其他12种与pALL高风险相关的CPS是否也可能从专科照护中获益,并指出这些需求常未被充分明确或满足。
  • 作者认为国际合作研究与共享数据对改善这些患者结局至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pediatric acute lymphoblastic leukemia (pALL) is the most common childhood malignancy, yet its etiology remains incompletely understood. However, over the course of three waves of germline genetic research, several non-environmental causes have been identified. Beginning with trisomy 21, seven overt cancer predisposition syndromes (CPSs)-characterized by broad clinical phenotypes that include an elevated risk of pALL-were first described. More recently, newly described CPSs conferring high risk of pALL are increasingly covert, with six exhibiting only minimal or no non-cancer features. These 13 CPSs now represent the principal known hereditary causes of pALL, and human pangenomic data indicates a strong negative selection against mutations in the genes associated with these conditions. Collectively they affect approximately 1 in 450 newborns, of which just a minority will develop the disease. As evidenced by tailored leukemia care protocols for children with trisomy 21, there is growing recognition that CPSs warrant specialized diagnostic, therapeutic, and long-term management strategies. In this review, we investigate the evidence that the 12 other CPSs associated with high risk of pALL may also see benefits from specialized care - even if these needs are often incompletely mapped or addressed in the clinic. Given the rarity of each syndrome, collaborative international research and shared data initiatives will be crucial for advancing knowledge and improving outcomes for these patients.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Stoltze U, Junk SV, Byrjalsen A, et al. Overt and covert genetic causes of pediatric acute lymphoblastic leukemia. Leukemia. 2025. PMID: 40128563. doi:10.1038/s41375-025-02535-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。